Hedge Fund Drops Million in Crinetics: Is It a Buy?
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Using financial plans to reach life objectives can streamline your path to success. Discover how to create a plan that works for you.
22,378 articlesA major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
California lawmakers move to tighten a five-year-old starter-home law, with SB 1116 clearing the Senate 37-0 and head...
California plans a one-time 5% wealth tax on roughly 200 billionaires to raise about $100B over five years. Even as m...
Orbs unveils V5, a Layer 3 hybrid that offloads DeFi execution off-chain while tying verification to Ethereum and Arb...
AMD's growth story is gaining steam as data centers, AI workloads, and CPU/GPU innovations align. This guide breaks d...
Quantum stocks are on a rebound after a rough patch. This guide breaks down why ionq, rigetti, d-wave surging matters...
Rivian is under renewed investor scrutiny as the R2 launch tests demand and governance structure limits shareholder i...
Cathie Wood goes bargain as Ark trims some bets and adds to three promising names. This piece breaks down the three s...
Oil volatility faded and mortgage demand held firm in the first half of 2026, underscoring resilience in the housing ...
Three leading egg producers settle with federal and state regulators over alleged price‑fixing, donating 53 million e...
On days when upbeat earnings flood the headlines, the Nasdaq sometimes slips instead of rallying. This article explai...
Nike's latest sponsorship moves suggest a gradual return of brand influence and profit potential. This article explor...